David Cragg - 01 Jun 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: Chief HR & Admin Officer
Signature: David W. Cragg
Issuer symbol: CYTK
Transactions as of: 01 Jun 2021
Net transactions value: -$229,896
Form type: 4
Filing time: 02 Jun 2021, 16:45:38 UTC
Next filing: 02 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$41,341	+6,562	+4.1%	$6.30^*	167,733	01 Jun 2021	Direct	F1, F2
transaction	CYTK	Common Stock	Sale	$141,919	-6,562	-3.9%	$21.63	161,171	01 Jun 2021	Direct	F1, F2
transaction	CYTK	Common Stock	Options Exercise	$53,153	+8,437	+5.2%	$6.30^*	169,608	01 Jun 2021	Direct	F1, F2
transaction	CYTK	Common Stock	Sale	$182,470	-8,437	-5%	$21.63	161,171	01 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Incentive Stock Option (right to buy)	Options Exercise	$0	-8,437	-100%	$0.000000^*	0	01 Jun 2021	Common Stock	8,437	$6.30	Direct	F1
transaction	CYTK	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-6,562	-100%	$0.000000^*	0	01 Jun 2021	Common Stock	6,562	$6.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021.
F2	Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.